Niclosamide-based metabolic anticance... - Advanced Prostate...

Advanced Prostate Cancer

21,581 members27,011 posts

Niclosamide-based metabolic anticancer drug's first clinical trial will target CRPC

Maxone73 profile image
1 Reply

Yes, they will start from castration resistant prostate cancer patients

biospace.com/article/releas...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
dhccpa profile image
dhccpa

I've never used niclosamide, although I've used other anthelmics.

Thanks for posting.

Not what you're looking for?

You may also like...

Phase 1-2 study for niclosamide-based drug:

or-niclosamide-based-drug/

New Drug BAY1841788 (ODM-201) has been successful for CRPC patients, Clinical trial Phase III completed.

This drug is for patients with Castration Resistance Prostate Cancer , apparently the clinical trial

Dr Slovin from MSKCC discusses treatments for advanced prostate cancer

approaches to Castration Resistant Prostate Cancer, for patients who need to know...

PSMA-targeted radiopharmaceutical clinical trials in the US

Now that the VISION trial of Lu-177-PSMA-617 is no longer recruiting, some patients are wondering...

Repurposing off label drugs for cancer/targeting metabolic pathways. Is anyone participating in this trial?

There is a trial underway at the Care Clinic in Harley Street that are seemingly trialing a similar...